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The Cys-loop receptor family of ligand-gated ion channels
are allosteric proteins (1– 4). Binding of neurotransmitter to the
receptor binding site located in the N-terminal domain induces
conformational changes (5), which propagate to the transmembrane domain (M1–M4)3 through the interface between these
two domains to open the gate, which is formed by M2 domains
(see Fig. 1A). Coupling through this interface is mainly mediated by noncovalent interactions between loops 2 and 7 (Cys-
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loop) from N-terminal domain and M2-M3 linker from the
transmembrane domain (see Fig. 1B) (6, 7). In addition, pre-M1
and M1 is the only covalent linkage between N-terminal
domain and transmembrane domain, which also play a role in
controlling channel gating (7). However, agonist binding does
not guarantee channel opening. With prolonged exposure to
neurotransmitters, most receptors are driven to a refractory
state, termed desensitization (8). At the single channel level,
desensitization appears as long-lasting nonconducting states
(9). Desensitization is a widespread phenomenon in most
ligand-gated ion channels. It plays an important role in shaping
synaptic transmission (10, 11). Desensitization of the Cys-loop
receptor family has been well characterized kinetically. It
involves dramatic increase in binding affinity to agonists (12,
13) and closure of the ion conducting pathway (9) with little
structural change in transmembrane domain (14). It is an
intrinsic property of the receptors (15).
Previous studies have identified numerous factors that can
influence desensitization. For example, desensitization is
dependent on agonists (16) and receptor subtypes (17, 18).
Mutations of a residue in the binding pocket (19) or between
two binding loops (20) influence desensitization. A study using
chimeric nAChR subunits suggests that two segments in the Nterminal domain are involved in desensitization (21). Another
study using serotonin receptor type 3 (5HT3R) chimeric with
␣7 nAChR fragments suggests that the interface between
N-terminal domain and transmembrane domain, especially
pre-M1 and the M2-M3 linker, is an important determinant for
desensitization (22). In addition, mutations of a pre-M4 residue
in the intracellular loop can alter desensitization (23). The most
dramatic influences on desensitization kinetics are from the
mutations in the pore-lining domain (M2). For example, introducing an aromatic residue to the M2 enhances desensitization
(24 –27), whereas substituting hydrophobic residues with
hydrophilic ones markedly slows desensitization (25, 28) or
even converts the fast desensitizing ␣7 nAChR to nondesensitizing (28). However, despite intensive studies in the past, the
molecular mechanism for desensitization of the Cys-loop
receptors is still poorly understood. There is no single mechanism that can explain most observations.
In this study, we proposed a novel hypothesis that uncoupling of N-terminal domain and transmembrane domain is a
major mechanism for receptor desensitization, and this uncoupling is mainly determined by the balance of coupling strength
(between loop 2/loop 7/M1 and M2-M3 linker) and gate tightJOURNAL OF BIOLOGICAL CHEMISTRY
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Binding of a neurotransmitter to its membrane receptor
opens an integral ion conducting pore. However, prolonged
exposure to the neurotransmitter drives the receptor to a refractory state termed desensitization, which plays an important role
in shaping synaptic transmission. Despite intensive research in
the past, the structural mechanism of desensitization is still elusive. Using mutagenesis and voltage clamp in an oocyte expression system, we provide several lines of evidence supporting a
novel hypothesis that uncoupling between binding and gating
machinery is the underlying mechanism for ␣7 nicotinic receptor (nAChR) desensitization. First, the decrease in gate tightness
was highly correlated to the reduced desensitization. Second,
nonfunctional mutants in three important coupling loops (loop
2, loop 7, and the M2-M3 linker) could be rescued by a gating
mutant. Furthermore, the decrease in coupling strength in these
rescued coupling loop mutants reversed the gating effect on
desensitization. Finally, coupling between M1 and hinge region
of the M2-M3 linker also influenced the receptor desensitization. Thus, the uncoupling between N-terminal domain and
transmembrane domain, governed by the balance of coupling
strength and gate tightness, underlies the mechanism of desensitization for the ␣7 nAChR.

Desensitization Mechanism of ␣7 nAChR
ness. We designed a series of experiments to test our hypothesis
using fast desensitizing ␣7 nAChR expressed in Xenopus
oocytes. First, we altered gate tightness by mutating the putative gating machinery to confirm and extend previous findings
of the gating effect on desensitization. Second, with double
mutations in coupling and gating regions, we observed the
mutual interaction between these two regions and their effects
on desensitization and channel gating. Finally, we defined the
residues that couple the M1 and the hinge region of M2-M3
linker responsible for desensitization.
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EXPERIMENTAL PROCEDURES
Mutagenesis and cRNA Preparation—The cDNA encoding
the wild type human ␣7 nAChR subunit was cloned into the
pGEMHE vector with T7 orientation. The residues in the loops
2 and 7 of the N-terminal domain, pre-M1 region, M2-M3
linker, and second transmembrane domain (see Fig. 1) were
mutated to cysteine or other residues, both for single and multiple mutations, using the PCR-based QuikChange method of
site-directed mutagenesis with PfuUltra DNA polymerase
(Agilent Technologies, Hercules, CA). The mutations were
confirmed by automated DNA sequencing (DNA laboratory,
Arizona State University, Tempe, AZ). The wild type and
mutant cDNAs were then linearized by NheI digestion. The
cRNAs were transcribed by T7 RNA polymerase (New England
Biolabs) using standard in vitro transcription protocols. After
digestion of the DNA template by RNase-free DNase I, the
cRNAs were purified and resuspended in diethyl pyrocarbonate-treated water. cRNA yield and integrity were examined on a
1% agarose gel (29).
Oocyte Preparation and Injection—Oocytes were harvested
from female Xenopus laevis (Xenopus I, Ann Arbor, MI) as
described previously (30) in accordance with the Institutional
Animal Care and Use Committee-approved protocol of Xenopus care and use. The stage VI oocytes were selected and incubated at 16 °C before injection. Micropipettes for injection were
pulled from borosilicate glass (Drummond Scientific, Broomall,
PA) on a Sutter P87 horizontal puller, and the tips were cut with
forceps to ⬇40 m in diameter. The cRNA was drawn up into
the micropipette and injected into oocytes with a Nanoject
micro-injection system (Drummond Scientific) with a total volume of 20⬃60 nl.
Two-electrode Voltage Clamp—One to three days after injection, an oocyte expressing ␣7 nAChR was placed in a homemade small volume chamber with continuous perfusion with
calcium free oocyte Ringer’s solution 2, which consisted of the
following: 92.5 mM NaCl, 2.5 mM KCl, 1.8 mM BaCl2, and 5 mM
HEPES, pH 7.5, to minimize activation of calcium sensitive
chloride channels in oocytes due to high calcium permeability
of the ␣7 nAChR. The oocyte Ringer’s solution 2 also contained
1 M atropine to avoid activation of muscarinic receptor in the
oocytes. The chamber was grounded through an agar salt
bridge to avoid the drug influence on junction potential
between the grounding silver wire and solution. The oocytes
were voltage clamped at ⫺60 mV to measure acetylcholineinduced currents using a GeneClamp 500B two-electrode voltage-clamp amplifier (Axon Instruments, Foster City, CA). The
current signal was low pass-filtered at 50 Hz with the built-in

four-pole low pass Bessel filter in the GeneClamp 500B twoelectrode voltage-clamp amplifier and digitized at 100 Hz with
a Digidata1440a digitizer and pClamp 10 software (Axon
Instruments).
Single Oocyte Binding—Four days after RNA injection, the
control or ␣7 nAChR-expressing oocytes (follicular membrane-free) were individually placed in a low binding 96-well
plate with a V-shaped bottom. The oocytes were individually
incubated in 15 l of 2 nM 125I-labeled ␣-bungarotoxin (125I-␣BTX, PerkinElmer Life Sciences) in oocyte Ringer’s solution 2
with 1% BSA in each well at room temperature for 2 h. Each
oocyte was then rinsed four times with 200 l oocyte Ringer’s
solution 2 with BSA with a 10-min incubation at room temperature for each rinse. The oocytes were then transferred into a
96-well scintillation counting plate (one oocyte per well). After
removing excess fluid, the oocytes were dissolved in 10 l 0.01
M NaOH, 0.1% SDS solution per well. The dissolved individual
oocytes were further disbursed in 200 l scintillation fluid overnight before scintillation counting (1 min per well) with a 1450
MicroBeta TriLux Scintillation and Luminescence counter
(PerkinElmer Life Sciences).
Drug Preparation—Acetylcholine chloride (ACh, SigmaAldrich) stock solution was prepared daily from the solid.
Mecamylamine hydrochloride (Tocris, Ellisville, MO) stock
solution was prepared and stored at ⫺20 °C in aliquots before
use.
Data Analysis—The dose-response relationship of the AChinduced current in recombinant ␣7 nAChRs was least-squares
fit to a Hill equation with Prism (version 4.0, GraphPad Software, Inc., San Diego, CA) to derive EC50 (the concentration
required for inducing a half-maximal current), Hill coefficient
(the slope factor), and maximum current. The maximum current was then used to normalize the dose response curve for
each individual oocyte. The average of the normalized currents
for each ACh concentration was used to plot the data. Statistical significance of the differences between wild type and mutant
log(EC50) values or between 125I-␣-BTX binding groups was
determined by analysis of variance with post hoc Dunnett’s test,
or Tukey’s multiple comparison test. Linear regression analysis
was used to determine significance of correlation between two
parameters. All data were presented as mean ⫾ S.E.. Each group
of data were confirmed in at least three oocytes. Coupling
energy (⌬⌬G) was determined by mutant cycle analysis with the
following equation: ⌬⌬G ⫽ RTln(⍀), where R is gas constant, T
is absolute temperature, and ⍀ is coupling coefficient (⍀ ⫽
(EC50wt.wt ⫻ EC50mut1.mut2)/(EC50mut1.wt ⫻ EC50wt.mut2))
(6, 31).
Homology Modeling—A three-dimensional model of the ␣7
nicotinic receptor subunit was made using Discovery Studio
software (version 1.7, Accelrys, San Diego, CA) running in a
Dell Precision 690 computer (Austin, TX). A single subunit was
modeled as the following. Briefly, the human ␣7 nicotinic
receptor subunit (1–303 and 413– 480) were aligned to the corresponding region of the ␣ subunit sequence of the Torpedo
nAChR (chain A) from the Protein Data Bank code 2BG9 with
modeler 9.0 in Discovery Studio software using “Align
Sequence with Structure” protocol with the blosum62 scoring
matrix, gap open penalty of ⫺200, gap extension penalty of
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⫺10, and default two-dimensional gap weights. The homology
model was then built using “Building Homology Models” protocol without optimization and loop refinement, and with predefined disulfide bridges in the cysteine loops and double cysteines in the binding loop C. The model was further energy
minimized for 400 steps of steepest descent minimization
method followed by 1000 steps of conjugated gradient using
minimization protocol with CHARMm force field. Structural
model presentations shown in Fig. 1 were generated with SwissPdbViewer (version 4.0) and POV-ray software (version 3.6) for
Windows.

RESULTS
Weakening Hydrophobic Interaction of Gating Residues
Shifted Dose-response Curve to Left and Reduced Receptor
Desensitization—The coupling between N-terminal domain
and channel-lining domain is mainly through noncovalent

Current
Mutants

EC50

Fold change
in EC50

nH

n

⫺3

1.28 ⫾ 0.09

6

⫺490
1
⫺2
⫺2
⫺658
1
1
⫺27
⫺61
⫺7
1

3.07 ⫾ 0.09
1.01 ⫾ 0.06
2.17 ⫾ 0.27
2.60 ⫾ 0.30
1.14 ⫾ 0.14
1.03 ⫾ 0.01
1.43 ⫾ 0.14
2.66 ⫾ 0.12
2.09 ⫾ 0.24
1.07 ⫾ 0.09
1.15 ⫾ 0.04

3
6
5
5
3
6
6
4
6
6
5

M

V246S
L247S
L248S (9⬘)
S249S (WT)
L250S
T251S
V252S (13⬘)
F253S
M254S
L255S (16⬘)
L256S (17⬘)
V257S
A258S
a
b

72.66 ⫾ 7.78a
nonfunctional
0.43 ⫾ 0.01a
210.52 ⫾ 24.29
98.67 ⫾ 10.82a
114.14 ⫾ 8.68b
0.32 ⫾ 0.01a
157.87 ⫾ 12.72
154.18 ⫾ 8.04
7.76 ⫾ 0.14a
3.47 ⫾ 0.16a
30.72 ⫾ 2.00a
266.30 ⫾ 33.71

p ⬍ 0.001 compared with wild type.
p ⬍ 0.01.

FIGURE 1. Homology model of the human ␣7 nAChR subunit. A, overall structure of a single subunit with a large part of the major intracellular loop missing
as original 4 Å EM structural template (Protein Data Bank code 2BG9) of the ␣ subunit of the Torpedo nicotinic receptor. Note that there are three important
functional domains in each subunit. The binding domain is located in the middle of the N terminus. The gating machinery is in the transmembrane domain,
mainly formed by 5-s transmembrane domains (M2s), one from each subunit. The coupling region between the two domains is formed by multiple loops as
detailed in B. B, a closer look of the coupling region, which is mainly contributed by loop 2 and loop 7 from the N-terminal domain and M2-M3 linker from the
transmembrane domain. Pre-M1 and the extracellular end of M1 are also in close proximity of the M3 side of the M2-M3 domain from a neighboring subunit
(not shown). The labeled residues are important coupling residues used in this study. C, a closer look of the M2 domain with the gating residues labeled.
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TABLE 1
EC50 values of ACh-induced currents in the M2 mutants of ␣7 nAChR

interactions (6, 32–34). The gating machinery is also formed by
noncovalent interactions (34 –36). Thus, tightness of the gate
relative to the coupling strength would influence the coupling
efficiency to transduce binding energy to the gating machinery.
Previous studies have demonstrated that mutations of the
hydrophobic gate-forming residues to hydrophilic ones significantly increase receptor sensitivity to agonist (37) and decrease
desensitization (25, 28). In extreme cases, these pore mutants
produce nondesensitizing receptors (28). To reproduce this
effect and further expand the covering region of the gating
machinery, we scanned the M2 region at 7⬘–19⬘ positions
(Val246–Ala258) with hydrophilic serine mutations. (The M2
positions are numbered from intracellular end starting with
Ile240 as 1⬘.) The EC50 values of these mutants are listed in Table
1. Fig. 2A demonstrates that hydrophilic mutations of the four
M2 residues resulted in a dramatic (⬎10-fold) leftward shift of
the dose-response curve when compared with that for the wild
type receptor. These four residues are highlighted in Fig. 1C.
The largest shift was produced by the mutation at 13⬘ position
(V252S), followed by 9⬘ position (L248S), and then 17⬘ (L256S)
and 16⬘ (L255S) positions. At the same time, the spontaneous
current in the absence of agonist was also evident in some
mutants. These currents were blocked by mecamylamine, the
noncompetitive antagonist of the ␣7 nAChR (Fig. 2B). For an
allosterically activated receptor, higher sensitivity to agonist
and spontaneously openings of hydrophilic mutants suggest
that the mutations at these positions have lowered the gating
energy, and the gating machinery is determined by the
hydrophobic interactions mainly at 9⬘ and 13⬘ positions and,
to a lesser extent, at 16⬘ and 17⬘ positions. Fig. 2C shows
typical traces from these mutants by a saturation concentration of ACh. Compared with the wild type, all four mutants
exhibited a marked decrease in desensitization. Fig. 2D plots

Desensitization Mechanism of ␣7 nAChR

the relationship between desensitization rate and fraction of
spontaneous current. Interestingly, the desensitization rate
was negatively correlated to the fraction of spontaneous current in log scale. Thus, the extent of the gating energy reduction, reflected by the fraction of spontaneous current (see
“Discussion” for details), was correlated to the degree of
reduced desensitization.
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FIGURE 2. Relationship of gating and desensitization. A, normalized and
averaged dose-response relationships for four mutants with significant shift
of the dose-response relationship when compared with the wild type receptor. EC50 values for these mutants, along with other mutants, are listed in
Table 1. Error bars are smaller than the symbols. Note that compared with the
wild type receptor, all four M2 mutants exhibited higher sensitivity to ACh.
B, spontaneous currents were evident when they were blocked by nAChR
antagonist mecamylamine (MCA). The maximal activatable currents were
determined by a saturation concentration of ACh. C, the rate of desensitization was slower in four gating mutants when compared with that for the wild
type receptor. D, the desensitization rate and fraction of spontaneous (spont.)
opening (spontaneous current/total current (spontaneous ⫹ activatable))
were highly correlated (p ⫽ 0.001; r2 ⫽ 0.9818).

Mutation of Putative Coupling Residues in Loop 2 Disrupted
Channel Function, Which Was Rescued by Gating Mutant—In
the Torpedo nAChR ␣ subunit, the coupling between binding
and gating domains is proposed to be mediated by the hydrophobic interaction between Val44 in loop 2 and Ser269–Pro272 in
the M2-M3 linker (34). The homologous residue of Val44 in ␣7
nAChR is a positively charged residue, Lys46. In our homology
model (Fig. 1B), this residue is close to the negatively charged
residue of Asp266 in the M2-M3 linker. Thus, the coupling of
binding and channel gating in ␣7 nAChR could be mediated by
a charge interaction. To test this hypothesis, we made multiple
mutations at these two residues. Mutations of Lys46 to Trp, Phe,
Cys, Asp, and Asn, and mutations of Asp266 to Cys, Leu, and Gln
resulted in nonfunctional channels (data not shown), suggesting the importance of both residues in channel function. However, K46A, K46Q, and D266A mutants were functional with no
discernable changes in desensitization kinetics (data not
shown). With some functional mutants, we further performed
mutant cycle analysis by measuring EC50 values for WT
(210.52 ⫾ 24.29 M, n ⫽ 6), K46R (239.53 ⫾ 23.03 M, n ⫽ 3),
D266E (355.37 ⫾ 30.60 M, n ⫽ 3), and K46A/D266A (810.90 ⫾
97.87 M, n ⫽ 3). The resulting coupling energy calculated from
above values indicated that there is only a very weak coupling
(⌬⌬G ⫽ 0.41 kcal) between these two residues, consistent with
the unified view of coupling mechanism in the Cys-loop receptor family (38) and the conclusion of unlikely pairwise interaction of these putative coupling residues in the ␣7 nAChR (39).
To further test the hypothesis that relative strength of coupling and gating energy govern the ultimate outcome of channel gating, we constructed double mutants with one nonfunctional loop 2 mutation and one gating mutation. The result
revealed that several nonfunctional mutants of Lys46 (K46C,
K46D, and K46N) were rescued by a gating mutant V252S (Fig.
3, A and B, with K46D and K46N shown). Notably, when compared with gating mutant V252S alone, the rescued double
mutants also exhibited a rightward shift of the dose-response
curve (Fig. 3C) and an increase in desensitization rate (Fig. 3D).
Thus, weakening the coupling strength can increase receptor
desensitization, (in the extreme case, such as nonfunctional
mutants, the agonist binding probably directly drives the receptor into the desensitized state without activating it), whereas
reducing the gate tightness can counteract that effect.
Nonfunctional Mutant of Loop 7 Coupling Residues Was Rescued by Gating Mutant—In addition to loop 2, several studies
have demonstrated that loop 7 (Cys-loop) is also important in
coupling between N-terminal domain and gating machinery in
␣7 nAChRs (39), GABAA receptor (6, 33), or ACh binding protein coupled to the C-terminal domain 5HT3R (32). To demonstrate similar importance of the balance between coupling
strength through loop 7 and gating energy in channel activation
and desensitization, we generated a mutant in several previously identified important coupling residues (V132I/R133Y/
W134N) in loop 7. Mutations of these residues totally impaired
channel functions (data not shown). However, with the combination of a gating mutation (V132I/R133Y/W134N/V252S),
the receptor became functional (Fig. 4A). Because weakening of
coupling strength would decrease channel gating efficiency,
rightward shifts of EC50 values for gating mutants by the cou-

Desensitization Mechanism of ␣7 nAChR

pling mutants were expected and experimentally confirmed
(Fig. 4B). At the same time, incorporation of nonfunctional
coupling mutants also significantly increased desensitization of
the gating mutant (Fig. 4C). Although we did not dissect individual contributions of these loop 7 coupling residues, the
above observation has already served for its purpose in supporting the notion that the balance between coupling strength and
gate tightness in determining desensitization kinetics is not
limited to loop 2 but also applicable to loop 7.
Nonfunctional Mutant D266C of M2-M3 Linker Was Rescued by Gating Mutant—Thus far, we have tested two important coupling loop mutants in the N-terminal domain for their
roles in receptor desensitization. Because the M2-M3 linker
from the transmembrane domain is also a key structural comJULY 15, 2011 • VOLUME 286 • NUMBER 28

ponent of coupling, here, we further tested whether the reduction of hydrophobic interaction at the channel gate could also
rescue nonfunctional mutants in this region. Asp266 has been
identified as a crucial coupling residue in the M2-M3 linker
(40). Thus, we tested the effect of a mutation of this residue on
channel function and desensitization. Our result demonstrated
that the D266C mutant was not functional (data not shown).
However, when we added a gating mutation (V252S), the double mutant receptor (D266C/V252S) became functional (Fig.
5A). The dose-response curve of the V252S mutant was shifted
to the right when the D266C mutation was introduced into the
channel (Fig. 5B). Concomitantly, desensitization kinetics also
speeded up for the same agonist concentration when compared
with V252S single mutant (Fig. 5C).
In above experiments, we used loss-of-function mutants in
the coupling region to demonstrate that the balance between
coupling strength and gating tightness govern the receptor gating and desensitization. Because there are no tightly coupled
residue pairs in the coupling region identified, it is not easy to
use cross-linking to strengthen coupling for the gain-of-funcJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Nonfunctional loop 2 mutants were rescued by a gating mutation with altered desensitization kinetics compared with the gating
mutant alone. A, the K46N mutant was not functional. However, addition of
V252S mutation to the K46N mutant rescued the function of the receptor.
B, the K46D mutant was not functional. However, addition of V252S mutation rescued the function of the receptor. C, the ACh dose-response relationships of the rescued receptors exhibited rightward shift (EC50 ⫽
13.40 ⫾ 0.32 M for K46D/V252S and EC50 ⫽ 2.04 ⫾ 0.05 M for K46N/
V252S) when compared with that for the V252S mutant alone (EC50 ⫽
0.32 ⫾ 0.01 M). Error bars are smaller than the symbols. D, the rescued
mutant receptors also had faster desensitization kinetics when compared
with the gating mutant alone (V252S ⫽ 15.60 ⫾ 0.58 s, n ⫽ 4; V252S/K46N ⫽
13.92 ⫾ 0.21 s, n ⫽ 4, p ⬍ 0.05; V252S/K46D ⫽ 12.95 ⫾ 0.49 s, n ⫽ 3, p ⬍ 0.05).

FIGURE 4. A nonfunctional loop 7 mutant (V132I/R133Y/W134N) could be
rescued by a gating mutation with altered desensitization kinetics compared with the gating mutant alone. A, the V132I/R133Y/W134N mutant
was not functional. However, addition of V252S mutation to the mutant rescued the function of the receptor. B, the ACh dose-response relationships of
the rescued receptor (V132I/R133Y/W134N/V252S) exhibited rightward shift
(EC50 ⫽ 0.56 ⫾ 0.02 M) when compared with V252S alone. Error bars are
smaller than the symbols. C, the rescued receptor had faster desensitization
kinetics when compared with the gating mutant alone (fraction of remaining
current relative to the peak after 10-s ACh application was 0.75 ⫾ 0.01 for the
rescued receptor (V132I/R133Y/W134N/V252S) and 0.98 ⫾ 0.01 for V252S
mutant alone; p ⬍ 0.001). Note that due to limited desensitization of the 10
M ACh-induced current in V252S, exponential fitting for time constant was
not successful.

Desensitization Mechanism of ␣7 nAChR

FIGURE 5. A nonfunctional mutant (D266C) in the M2-M3 linker could be
rescued by a gating mutation with altered desensitization kinetics compared with the gating mutant alone. A, the D266C mutant was not functional. However, addition of V252S mutation to the mutant rescued the function of the receptor. B, the rescued receptors (D266C/V252S) exhibited
rightward shift of the ACh dose-response relationship (EC50 ⫽ 1.15 ⫾ 0.05 M)
when compared with the V252S mutant. C, the rescued receptor had faster
desensitization kinetics when compared with the gating mutant alone; the fraction of remaining current relative to the peak after a 10-s ACh application was
0.81 ⫾ 0.03 for the rescued receptor and 0.98 ⫾ 0.01 for V252S alone (p ⬍ 0.01).

tion influence on receptor desensitization. In fact, our attempt
using an oxidation agent in several double cysteine mutants
such as K46C/D266C and several pairs of adjacent residues
between loop 2 and M2-M3 linker failed to produce functional
channels. This precluded us from further pursuing the crosslinking study in the coupling region. (Note that reducing agents
can break disulfide bonds in the binding loop C and make channels nonfunctional.) Nevertheless, our data are strong enough
to support our hypothesis.
To exclude the possibility that non-functional mutants used
in above rescue experiments were due to complete absence of
the mutant receptors in the plasma membrane, we performed
125
I-␣-BTX binding assay for oocytes expressing mutant or
wild type receptors compared with the non-expressing control.
Fig. 6 shows that these mutant receptors exhibited significantly
higher 125I-␣-BTX binding than the control. Thus, these nonfunctional mutants all have surface expression, although the
level of binding of these mutants was reduced when compared
with that for the wild type receptor. Lower binding of the
mutant receptors is likely due to different batches of the cRNAs
synthesized using different batches of the RNA CAP structure.
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When we measured binding using the oocytes injected with
new cRNAs, the 125I-␣-BTX binding of mutant receptors is
indistinguishable from the wild type receptor (data not shown).
The extent of the reduced binding in Fig. 6, however, cannot
explain total loss of function in these mutants, further suggesting that complete uncoupling is mainly responsible for the total
loss of function in these mutants.
Coupling between M1 and M2-M3 Linker Also Influences
Desensitization Kinetics—A study of 5-HT3R with the chimeric
incorporation of ␣7 nAChR segments also pointed out another
important mechanism for channel gating and desensitization
(22). That study demonstrated that the pre-M1 and beginning
of M1 can interact with the end of M2-M3 linker, and such an
interaction determines channel activation and desensitization
kinetics. However, the underlying interacting residues have not
been determined yet. It is also not clear whether the similar
coupling between M1 and M2-M3 linker is also an important
gating determinant in the ␣7 receptor-based chimera. To identify important residues in this potential coupling region in ␣7
nAChR, we scanned the M2-M3 linker (Asp266 to Tyr274) with
cysteine mutagenesis. Our results indicated that majority of
mutants either were nonfunctional (e.g. D266C and S267C) or
had very low expression levels (e.g. P269C, L270C, I271C, and
Y274C), suggesting that residues at these positions are important in channel function. The V268C mutant was functional but
with strong desensitization (data not shown). However, two
mutants, A272C and Q273C, exhibited slowed desensitization
kinetics (Fig. 7A). Interestingly, ␣7A272 is homologous to the
VOLUME 286 • NUMBER 28 • JULY 15, 2011
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FIGURE 6. Nonfunctional mutant receptors, used in the rescuing experiments in Figs. 3–5, exhibited 125I-␣-BTX binding above the background.
The bar graph represents the average 125I-␣-BTX bindings in the mutant and
wild type receptor-expressing single oocytes or nonexpressing controls.
Number of oocytes used in the binding experiments in each group is indicated in each bar. The p values for analysis of variance post hoc multiple
comparison tests are shown below the bar graph. Note that the binding in the
control oocytes represents nonspecific binding, and all mutant and wild type
receptor-expressing oocytes exhibited higher-than-background binding,
suggesting that all these mutant receptors have some level of surface expression. Note that all the mutant-expressing oocytes had lower binding values
compared with the wild type-expressing oocytes, although with a similar
amount of cRNA injection. After subtracting background control value, their
specific bindings are 16.5% (K46D), 19.7% (K46N), 25.9% (D266C), and 54.3%
(V132I/R133Y/W134N) of the wild type binding.

Desensitization Mechanism of ␣7 nAChR

FIGURE 7. Interaction between M1 and the M2-M3 linker altered the ␣7
nAChR desensitization. A, M2-M3 linker mutagenesis scanning resulted
identification of two positions that can slow the channel kinetics upon mutations (with sample current traces of several mutants). Note that some mutants
such as A272C exhibited double exponential decay, and in others, such as
A272W, agonist block was evident (with a hump current after switching to
control solution). Thus, in correlation analysis, we use fraction remaining at
10 s of ACh application, instead of time constant of current decay. B, a sevenresidue (208 –214) substitution in pre-M1 abolished the slow component of
A272C mutation, whereas a six-residue (208 –213) substitution (without
mutation at Asn214) had no effect on the current kinetics. C, N214S/A272C
double mutants further confirmed that Asn214 interacting with A272C is an
important determinant for desensitization.

putative hinge residue of ␣1Gly275 in the Torpedo nAChR (34).
To address whether the slowed desensitization is due to an
increase in side chain size and thus a decrease in hinge flexibility, we performed all possible substitutions of this putative
hinge residue (Ala272). Three mutants (A272K, A272R, and
A272P) were nonfunctional (data not shown). The remaining
functional mutants showed different degrees of desensitization.
Because some mutants exhibited a double exponential decay,
we used the fraction of the remaining current after decaying
from the peak as a parameter. Note that the fraction of the
remaining current after a 10-s application of 100 M ACh was
positively correlated to the side chain volume (Fig. 7A, p ⫽
0.0113) at position 272, suggesting that hinge hypothesis may
play a role in the desensitization of ␣7 nAChR. That is, the more
JULY 15, 2011 • VOLUME 286 • NUMBER 28

DISCUSSION
Despite intensive research in the past, the mechanism of
desensitization of the Cys-loop receptors is still not completely
clear. To this end, we provided several lines of evidence to support the hypothesis that uncoupling between loop 2/loop 7/M1
and M2-M3 is an important mechanism for desensitization,
and this uncoupling is mainly governed by the balance between
coupling strength and relative tightness of gating machinery.
First, hydrophilic substitution of a gating residue dramatically
reduced desensitization; and the change of desensitization was
correlated to the extent of spontaneous current. Second, lossof-function mutations of many putative coupling residues in
loop 2, loop 7, and the M2-M3 linker were rescued by gating
mutations. At the same time, the double mutants in the coupling and gating regions demonstrated the effect of mutual
interaction of the two regions on desensitization kinetics.
Finally, interaction between M1 and M2-M3 linker was also an
important determinant for the receptor desensitization. Thus,
strength of coupling energy relative to gating energy determines the likelihood of uncoupling and thus the extent of
desensitization.
Our results and hypothesis can be best illustrated in Fig. 8 in
terms of gating energy and coupling energy. When the bound
agonist molecules induce conformational changes in the N-terminal domain to a high affinity state (flip state), the binding
energy is then transmitted to the channel gate through the coupling region. The efficiency of this energy transduction from
binding site to channel gate is probably dependent on the coupling strength relative to the gate tightness, which, in turn,
JOURNAL OF BIOLOGICAL CHEMISTRY
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flexible the hinge, the faster desensitization kinetics for the
receptor.
Alternatively, the size of side chain could influence coupling
to other part of the receptor, and this coupling would contribute to its desensitization kinetics. As mentioned above, the
interaction between M1 and the M2-M3 linker is an important
determinant for receptor desensitization. We then replaced
TLYYGLN sequence in the M1 region of ␣7 nAChR with the
homologous sequence PLFYAVS from 5-HT3R. When this chimera was added to the A272C mutant, the slowing effect on
desensitization by A272C was abolished (Fig. 7B, left panel),
suggesting coupling between Ala272 and the M1 segment is also
important for the receptor desensitization. In contrast, when a
shorter sequence of TLYYGL was replaced by PLFYAV, the
chimera did not abolish the slowing effect of A272C on desensitization (Fig. 7B, right panel). Using this approach, we identified that Asn214 in M1 is an important residue for the receptor
desensitization. In fact, with double mutation (N214S/A272C),
N214S alone is enough to abolish the slowing effect of A272C
on the receptor desensitization (Fig. 7C). Thus, the coupling
between Asn214 and Ala272 mutants could influence receptor
gating and desensitization. Coupling energy (⌬⌬G ⫽ 0.97 kcal)
calculated from the EC50 values of the wild type (210.52 ⫾ 24.29
M, n ⫽ 6), N214S (97.37 ⫾ 8.72 M, n ⫽ 3), A272C (30.84 ⫾
0.67 M, n ⫽ 3), and N214S/A272C (73.29 ⫾ 2.97 M, n ⫽ 4)
mutants also suggests that these two residues, probably
between two neighboring subunits, are coupled with intermediate coupling strength.

Desensitization Mechanism of ␣7 nAChR

determines the probability of the receptor going to a desensitized state. In wild type ␣7 nAChR, the coupling energy could
be slightly lower than the gating energy, so that the receptor has
fast desensitization. However, if the gating energy is markedly
reduced, as in the cases of L248S and V252S, then the coupling
energy is significantly higher than the gating energy. Under this
condition, the uncoupling becomes unlikely, and desensitization is very limited. If the reduction of gating energy barrier is
less dramatic, as in L255S and L256S mutants, the coupling
energy could be similar to (or slightly higher than) the gating
energy. In this case, the uncoupling is evident, and desensitization is intermediate. On the other hand, if the coupling strength
is reduced dramatically, as in the cases of K46(D/N), D226C,
and V132I/R133Y/W134N mutants, then the coupling energy
is not enough to transduce binding energy to the gating
machinery for channel opening. Under these conditions, the
receptor is nonfunctional. In other words, upon agonist binding, all the receptors directly go to the desensitized state without activation. However, these nonfunctional mutants still have
some subthreshold coupling strength for channel activation.
Thus, when the energy barrier for activation was lowered with
introduction of V252S mutation, the receptor becomes functional again, but with a slightly higher desensitization rate than
the gating mutant alone.
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Our hypothesis is not only consistent with our current findings but also can explain other M2 mutational effects on desensitization. For example, aromatic substitutions in the M2
domain (24, 25) would strengthen the hydrophobic interaction
of the gating residues and thus increase tightness of the channel
gate and enhance desensitization. Hydrophilic substitutions
would weaken the energy barrier for channel opening, thus
requiring less coupling energy and binding energy to open the
channel and with reduced desensitization (25, 28). Although in
this study, we focused on the balance of coupling and gating,
our hypothesis does not exclude the possibility that other
regions in the receptor subunits could impact desensitization.
In most cases, we can interpret their effects on desensitization
by indirect influence of coupling and gating.
Conducting Desensitized State—Hydrophilic mutation of the
conserved M2 leucine L247T of the chicken ␣7 nAChR, which
is homologous to L248T of the human ␣7 nAChR, created a
high conductance state (80 ps). Based on this new conductance
state, it has been proposed that the gating mutation created
conducting desensitized state (28, 41). However, high conductance state is the only conducting state opened by low concentration of ACh or by its antagonists. Higher ACh concentration
can induce openings with both normal conductance and high
conductance. If the high conductance state is the desensitized
VOLUME 286 • NUMBER 28 • JULY 15, 2011
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FIGURE 8. Channel opening and desensitization is determined by the balance of binding, coupling, and gating regions. A, a schematic presentation of
three energetic hot spots for channel function: binding, coupling, and gating. In the resting state, the coupling region is intact, and the channel gate is closed
(left). Upon agonist binding, the binding energy induces conformational changes of the receptor to overcome the gating energy barrier to open the channel
through the stressed coupling region (middle panel). The stressed coupling region can break, which will cause uncoupling between binding site and channel
gate. This uncoupling is desensitization (right). The likelihood of uncoupling depends on the relative strength of coupling and gating machinery as illustrated
in B. B, putative energy profile in coupling and gating regions and their relationship to desensitization in the wild type and mutant receptors. Egating, the energy
needed to break the gating energy barrier to open the channel; Ecoupling, energy needed to break the coupling energy barrier to desensitize the receptor. Thus,
it is the relative strength of coupling energy and gating energy determine the degree and rate of desensitization.
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bic interaction between the intracellular residues could counteract the gating residues to stabilize receptor in the open state,
reducing the gating energy and decreasing likelihood of uncoupling and desensitization.
Subunit-dependent Desensitization—The desensitization rate
and level varies greatly with different members of this receptor
family. Even within a subfamily, different subtypes of receptors
also show dramatic difference in desensitization. For example,
the desensitization rate among the heteromeric nAChRs are in
the following order: ␣3␤2 ⬎ ␣4␤2 ⬎ ␣3␤4 ⬎ ␣4␤4 (18). The
difference in desensitization among different subfamilies or
subtypes could arise from variations in less important binding
residues and in many important coupling residues. Even in the
transmembrane domain, many residues are not absolutely conserved. Thus, variations in binding affinity, coupling strength,
and gate tightness in different subunits can influence the
uncoupling of binding and gating directly or indirectly. Because
desensitization can help shape synaptic transmission (10), evolution must play a critical role in optimizing the receptor subunits for the receptor desensitization kinetics to match their
functional role in synaptic transmission and extrasynaptic
activity.
Desensitization without Activation—Activation of the Cysloop receptor involves conformational change (flip state) in the
binding site before channel gating (1, 48). In the case of a highly
desensitizing channel, such as ␣7 nAChR, our data suggest that
weak coupling strength relative to strong gate tightness makes
it highly possible that uncoupling can occur before channel
opening. In fact, cyclical desensitization model proposed more
than 50 years ago has correctly predicted the possibility of
desensitization without activation (8). In our data, the nonfunctional mutants in coupling region could be 100% desensitization without activation because of insufficient coupling energy
for those mutant channels to open.
Two-gate Mechanism—It has been proposed that the nicotinic receptor has a desensitization gate in addition to the activation gate (49), similar to the “ball and chain” mechanism of
the N-type inactivation of potassium channels, except that
these two gates are mutually coupled. With this model, desensitization rate is much faster in the activated receptor than the
resting receptor, and recovery from desensitization requires
one more state with two discrete evens, i.e. opening of desensitization gate and closing activation gate, along with the changes
in interaction between the two gates. The key point for the
two-gate mechanism is that the activation gate is still in the
open position after desensitization. A study using the cysteine
accessibility test does not support an entirely separate desensitization gate or that the activation gate remains open in desensitized state (50). If the activation gate is closed in the desensitized state, then the two-gate model would be indistinguishable
from the one-gate allosteric model with the uncoupling mechanism for desensitization as we proposed. In this case, in the
open state, the tension sensed by the coupling loops is much
higher than that in the resting state. Thus, the receptor is more
likely to become uncoupled in the open state than in the closed
state. In addition, when the M2 domain is uncoupled to the
N-terminal domain, the conformation of this channel-lining
domain does not necessarily need to be the same as in the restJOURNAL OF BIOLOGICAL CHEMISTRY
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state, the opposite concentration dependence for the high conductance state should be expected because a higher concentration of agonist would induce more desensitization. In addition,
the M2 9⬘ residue is not the only residue that forms the channel
gate. At least three more residues at 13⬘ (34), 16⬘, and 17⬘ (this
study) also form the energy barrier for channel gating. Furthermore, the major selectivity filter is located in the intracellular
end of M2 (42). Interestingly, recent crystal structure studies of
bacterial pentameric proton-gated ion channels (43, 44) suggest a M2-M3 tilting model for channel activation. In this
model, M2-M3 tilting opens extracellular half of the pore and
restricts the intracellular end of the pore for ionic selectivity
and single channel conductance. Protonation scanning of M2
domain also supports the pore dilation mechanism in a nAChR
(45). Thus, it is possible that L247T mutation decreases the
gating energy barrier and creates an intermediate state with
partial tilting of M2-M3, which opens the gate with less restriction in the intracellular end of the pore, resulting in a larger
single channel conductance. In the wild type receptor, this partial tilting does not exist probably because higher energy barrier
for channel gating prevents this partial conformational state.
Role of N-terminal Domain in Desensitization and Recovery—
The molecular basis for faster desensitization of ␤2 subunitcontaining nAChR than ␤4 subunit-containing nAChR lies in
the N-terminal domain, mainly in two segments located in the
top of the receptor (21). Although detailed residues underlying
this difference have not been identified, it is clear that multiple
residues in the N-terminal domain, with perhaps mutual interactions, are responsible for the different desensitization kinetics. How is this phenomenon related to uncoupling? One possibility is that interactions between the two segments in the ␤2
subunit create an energy trap in the N-terminal domain to
increase binding affinity and to facilitate over-rotation in the
N-terminal domain, resulting in extra stress on the coupling
region. Thus, conformational change in the N-terminal domain
can indirectly influence uncoupling of the binding and channel
gate. The energy trap created by additional interactions is further supported by agonist-independent recovery of high affinity
desensitization state. The subunit rearrangement in the N-terminal domain would bring some residues in the interacting
range. For example, transient interactions between loop C and
␤7 (46) or between binding loops C and F (47) upon channel
activation might also influence desensitization and recovery. In
this sense, conformational changes in the N-terminal domain
in both activation and desensitization could be very similar, but
with different degrees.
Role of Intracellular Loop—The pre-M4 region of the M3-M4
intracellular loop is in close proximity to the selectivity filter
formed by the pre-M2 and M2 domains. Hydrophobicity of
mutants of a conserved arginine in 5HT3R is positively correlated to the time constant of desensitization (23). This relationship is opposite to the effect of hydrophobicity of gating residues on the receptor desensitization. It is possible that channel
opening causes restriction of intracellular end of the pore as
suggested by two recent studies with bacterial proton-gated ion
channels (43, 44). Narrowing of the intracellular end of the pore
may also bring pre-M4 hydrophobic residues together to the
range for their hydrophobic interaction. As a result, hydropho-
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ing state. Finally, recovery from desensitization clearly requires
an extra step for recoupling. This would be equivalent to the
reopening of the desensitization gate. In this sense, the coupling
machinery can serve as the “desensitization gate,” but working
in a reversed manner.
In summary, we have proposed an uncoupling mechanism
for Cys-loop receptor desensitization. We provided several
lines of evidence to support that the balance between coupling
strength and gate tightness is the major determinant for uncoupling that underlies receptor desensitization. Thus, loose coupling and tight gating machinery render the ␣7 nAChR a highly
desensitizing receptor. Other previously reported factors such
as conditional interactions of N-terminal domain, which may
stabilize the receptor in desensitized states, and intracellular
domain properties, which may stabilize the receptor in the open
states, can also be explained by their indirect influence on coupling. Because this hypothesis can explain many experimental
data from other receptor types in the Cys-loop receptor family,
it is likely a general mechanism of desensitization in this receptor family.
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